Content Type

Displaying 812 result(s)

Sales crediting—or “stacking”—gets a bad rap, but it’s not always deserving of it. Here are four tips to ensure that your sales org has the right amount of stacking, and how it can benefit the team as a whole.

When it comes to defending your organization against incoming biosimilars, there’s no one-size-fits-all approach. Here’s how to plan a defense against biosimilar entry, and the four major risks of planning too late.

Trump’s blueprint for lowering drug prices is more positive for pharma companies than the POTUS’s rhetoric had suggested, but that doesn’t mean that pharma companies can rest on their laurels. It’s time to formulate a proactive plan that continues to put American patients first.

Digital health is moving beyond fitness trackers. Here are four ways that it can help medtech companies improve their go-to-market strategies, and why medtech should be driving adoption in the life sciences industry.